Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1)

Shusaku Shibutani1, Hana Okazaki2, Hiroyuki Iwata3

  • 1From the Laboratory of Veterinary Hygiene, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan shushibu@yamaguchi-u.ac.jp.

Insights

Endocytosis, specifically amino acid uptake via dynamin, is crucial for activating mechanistic target of rapamycin complex 1 (mTORC1). Inhibiting endocytosis blocks mTORC1 activation and nutrient utilization, offering new therapeutic strategies.

Area of Science:

  • Cellular Metabolism
  • Molecular Biology
  • Endocytosis

Background:

  • Mechanistic target of rapamycin complex 1 (mTORC1) regulates protein synthesis and cellular metabolism.
  • mTORC1 activity is controlled by extracellular amino acid availability.
  • Amino acids are transported to the lysosome to activate mTORC1 via Rag GTPases and Rheb.

Purpose of the Study:

  • To elucidate the mechanism by which extracellular amino acids reach the lysosomal lumen and activate mTORC1.
  • To investigate the role of endocytosis in mTORC1 activation.

Main Methods:

  • Inhibition of endocytosis using dominant-negative dynamin 2 or pharmacological inhibitors of dynamin and clathrin.
  • Assessment of mTORC1 recruitment to the lysosome.
  • Manipulation of intracellular amino acid levels and Rag GTPase activity.

Main Results:

  • Dynamin-dependent endocytosis is critical for mTORC1 activation.
  • Inhibition of endocytosis inactivates mTORC1 and prevents its lysosomal recruitment.
  • mTORC1 inactivation due to endocytosis inhibition is caused by amino acid deprivation.
  • Endocytosis inhibition does not induce autophagy.

Conclusions:

  • Amino acid uptake via dynamin-dependent endocytosis is essential for mTORC1 activation.
  • Endocytosis inhibitors can potentially block nutrient utilization and inhibit mTORC1 signaling.
  • These findings suggest novel therapeutic approaches targeting nutrient utilization in diseases like cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.7K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K